Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Agency: Food and Drug Administration
Assistance Listings: 93.103 -- Food and Drug Administration Research
Description
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Grantor contact information
Description
Email: Kimberly.Pendleton@fda.hhs.gov
Documents
No documents are currently available.
Link to additional information
Closing: February 8, 2028
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$600,000
Award Maximum
Funding opportunity number:
RFA-FD-25-017
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Agriculture
Consumer protection
Food and nutrition
Category Explanation:
History
Version:
3
Posted date:
July 11, 2025
Archive date:
March 9, 2028
